OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Animal Models of Multiple Sclerosis
Paul A. Smith
Current Protocols (2021) Vol. 1, Iss. 6
Closed Access | Times Cited: 15

Showing 15 citing articles:

Increased regulatory activity of intestinal innate lymphoid cells type 3 (ILC3) prevents experimental autoimmune encephalomyelitis severity
Milica Lazarević, Goran Stegnjaić, Bojan Jevtić, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 4

Adipose‐derived mesenchymal stem cells ameliorates experimental autoimmune encephalomyelitis via modulation of Th1/Th17 and expansion of Th2/Treg responses
Simin Zargarani, Maryam Jadid Tavaf, Azita Soltanmohammadi, et al.
Cell Biology International (2024) Vol. 48, Iss. 8, pp. 1124-1137
Closed Access | Times Cited: 4

Aptamer-based electrochemical nanobiosensor for research and monitoring of multiple sclerosis in mice models
Marina Serin, Pınar Kara
Bioelectrochemistry (2024) Vol. 160, pp. 108744-108744
Closed Access | Times Cited: 3

A novel PROTAC molecule dBET1 alleviates pathogenesis of experimental autoimmune encephalomyelitis in mice by degrading BRD4
Ziwei Song, Jin Li, Yijie He, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112646-112646
Closed Access | Times Cited: 2

Advancements in Neurodegenerative Diseases: Pathogenesis and Novel Neurorestorative Interventions
Wenyong Gao, Shiyuan Jing, Chao He, et al.
Journal of Neurorestoratology (2024), pp. 100176-100176
Open Access | Times Cited: 2

Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis
Xuxu Xu, Chaowei Han, Pengcheng Wang, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 5

The validity of animal models to explore the pathogenic role of the complement system in multiple sclerosis: A review
Nil Saez-Calveras, Amy L. Brewster, Olaf Stüve
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 8

Effects of Calorie Restriction on Multiple Sclerosis: A Review of the Preclinical and Clinical Studies
Parinaz Javanbakht, Fatemeh Taghizadeh, Fatemeh Shirani Takabi, et al.
Neurochemical Research (2023) Vol. 48, Iss. 6, pp. 1597-1610
Closed Access | Times Cited: 4

Remibrutinib (LOU064) inhibits neuroinflammation driven by B cells and myeloid cells in preclinical models of multiple sclerosis
Barbara Nuesslein‐Hildesheim, Enrico Ferrero, Cindy Schmid, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 4

Liposome-Assisted Drug Delivery in the Treatment of Multiple Sclerosis
Giuliana Greco, Maria Grazia Sarpietro
Molecules (2024) Vol. 29, Iss. 19, pp. 4689-4689
Open Access | Times Cited: 1

Novel liposomal glatiramer acetate: Preparation and immunomodulatory evaluation in murine model of multiple sclerosis
Niloufar Rahiman, Parvin Zamani, Leila Arabi, et al.
International Journal of Pharmaceutics (2023) Vol. 648, pp. 123620-123620
Closed Access | Times Cited: 2

Suppression of Multiple Sclerosis by Ultraviolet Light
Lori A. Plum, Hector DeLuca
Medical Research Archives (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 1

Page 1

Scroll to top